# CVM GFI #191 Changes to Approved NADAs - New NADAs vs Category II Supplemental NADAs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-191-changes-to-approved-nadas-new-nadas-vs-category-ii-supplemental-nadas/33b97e61-bc96-497e-9004-842c9543f2f4

> FDA guidance document: CVM GFI #191 Changes to Approved NADAs - New NADAs vs Category II Supplemental NADAs. Issue date: August 27, 2020. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #191 Changes to Approved NADAs - New NADAs vs Category II Supplemental NADAs
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2020-08-27
- Last Changed: 2020-08-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0614">FDA-2008-D-0614</a>

## Related Documents

- [CVM GFI #271 Reporting and Mitigating Animal Drug Shortages](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-271-reporting-and-mitigating-animal-drug-shortages/b4f6fa83-203d-48af-8eb2-4ceebf9e2d16)
- [CVM GFI #261 - Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-261-eligibility-criteria-for-expanded-conditional-approval-of-new-animal-drugs/f14b98b9-4e54-4fbf-8ced-f5788ccefc39)
- [CVM GFI #199 Animal Generic Drug User Fees and Fee Waivers and Reductions](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-199-animal-generic-drug-user-fees-and-fee-waivers-and-reductions/6fc52a11-514e-4e9d-90b6-c79ef576ec6f)